Abstract:Background. Acute tonsillopharyngitis is one of the most common types of respiratory tract infections. In case of bacterial etiologies of the disease, penicillin antibiotics are prescribed, in particular amoxicillin + clavulanic acid. Dispersible forms of antibiotics have a number of advantages over film-coated tablets and are characterized by better pharmacokinetic parameters that increase the effectiveness and safety of treatment, as well as patient compliance. Aim. To compare the effectiveness and safety of Amoxicillin + Clavulanic acid EXPRESS in the form of dispersible tablets and amoxicillin with clavulanic acid in film-coated tablets in the treatment of acute streptococcal tonsillopharyngitis. Materials and methods. A randomized comparative clinical study involved 60 adult patients diagnosed with acute streptococcal tonsillopharyngitis. Group 1 (n=30) received the Amoxicillin + Clavulanic acid EXPRESS, dispersible tablets, 875+125 mg 2 times a day at the beginning of meals. Group 2 (n=30) received Amoxiclav, film-coated tablets, 875+125 mg 2 times a day at the beginning of meals. The duration of the treatment was 10 days. The following procedures were performed to all participants: general clinical and otorhinolaryngological examinations, an express test to detect group A streptococcal antigens in a smear from the posterior pharyngeal wall (streptatest), assessment of symptoms of acute tonsillopharyngitis on the McIsaac scale, severity of sore throat, difficulty swallowing, swelling of the throat, measurement of body temperature, assessment of the clinical global impression of the therapy, adherence to treatment, frequency of the adverse reactions before treatment, 3 days after the beginning of therapy and after the course completion (day 10). Results. Recovery occurred in 96.6% of patients in group 1 according to examination on the 10th day of treatment and in 93.3% of patients in group 2. The rate of fever regression was higher in group 1 – on the 3rd day of treatment, normalization of temperature was observed in 36.6% and 30% of patients in the comparison group. Pain syndrome, symptoms of throat swelling and difficulty swallowing significantly (p0.01) regressed by the 10th day in patients of both treatment groups. The incidence of adverse reactions on the 10th day of treatment in group 1 was 10%, in group 2 – 33.3% (p=0.03). Conclusion. Amoxicillin + Clavulanic acid EXPRESS has high therapeutic efficacy in the treatment of acute streptococcal tonsillopharyngitis, comparable to the Amoxiclav in film-coated tablets. At the same time, dispersible tablets of Amoxicillin + Clavulanic acid EXPRESS demonstrated a significantly higher safety profile compared to the simple tablet form.

A Randomized Controlled Clinical Trial on the Effect of Amoxicillin/Sulbactam and Amoxicillin /clavulanate Potassium in the Treatment of Acute Bacterial Infections

Bacteriological Efficacy of Amoxicillin/sulbactam on Acute Bacterial Infections

A Multicenter Randomized Double Blind Parallel Control Clinical Trial for Amoxicillin and Clavulanate Potassium Chewable Tablet in the Treatment of Acute Bacterial Infections

Clinical Randomized Controlled Trial of Amoxycillin-sulbactam Injection in the Treatment of Bacterial Infection

A randomized controlled open study of ampicillin/sulbactum in the treatment of 172 cases with bacterial infections

A Multicenter,randomized Controlled Clinical Trial of Imported Amoxicillin-Sulbactam in the Treatment of Community-Acquired Pneumonia

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

Clinical evaluation of sulbactam/ampicillin

Multicenter Clinical Study on Piperacillin/Sulbactam for Treatment of Respiratory and Urinary Tract Infection

Clinical Trial on Augmentin Against Acute Exacerbation of Chronic Bronchitis (AECB) in Adults

Antibacterial therapy for acute streptococcal tonsillopharyngitis: results of a randomized comparative clinical trial with amoxicillin + clavulanic acid EXPRESS

Comparison of Short-Term Therapeutic Effects between Amoxicillin-Clavulanic Acid and Ceftriaxone Sodium on Febrile Urinary Tract Infections in Children under Five Years Old

Pharmacokinetics and pharmacodynemics of amoxicillin/clavulanic acid potassium in healthy volunteers

Efficacy of Cefoperazone/sulbactam 2∶1 Vs Cefoperazone/sulb Actam 1∶1 in Treatment of Lower Respiratory Tract Infections

The Study on Antibacterial Activity of Amoxicillin Sulbactam Compared with Other Four Antimicrobial Agents in Vitro

Meta-analysis of the clinical efficacy of amoxicillin-clavulanic acid formulations for acute respiratory infections in children

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections

A multicenter,randomized,and double-blind controlled clinical trial of cefepime in treatment of acute bacterial infections

Pharmacokinetics of Amoxicillin and Clavulanate Potassium for Suspension (200 mg/28.5 mg) in Healthy Subjects: Sample Add Stabilizer Study and Food Effects

A Randomized Controlled Clinical Trial of Piperacillin/Tazobactam Versus Imipenem/Cilastatin in the Treatment of Bacterial Infections

Clinical Study of Inhaled Ambroxol in the Adjunctive Treatment of Lower Respiratory Tract Infection Induced by Pseudomonas Aeruginosa